Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLBTW
Upturn stock ratingUpturn stock rating

Cellebrite DI Equity Warrants (CLBTW)

Upturn stock ratingUpturn stock rating
$5.25
Delayed price
Profit since last BUY119.67%
upturn advisory
Regular Buy
BUY since 85 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/16/2024: CLBTW (3-star) is a STRONG-BUY. BUY since 85 days. Profits (119.67%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 48.03%
Avg. Invested days 36
Today’s Advisory Regular Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/16/2024

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio 93.72
1Y Target Price -
Price to earnings Ratio 93.72
1Y Target Price -
Volume (30-day avg) 373464
Beta 1.52
52 Weeks Range 0.70 - 5.94
Updated Date 10/15/2024
52 Weeks Range 0.70 - 5.94
Updated Date 10/15/2024
Dividends yield (FY) -
Basic EPS (TTM) 0.06

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -28.51%
Operating Margin (TTM) 13.05%

Management Effectiveness

Return on Assets (TTM) 6.39%
Return on Equity (TTM) -1768.51%

Valuation

Trailing PE 93.72
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 81195287
Shares Outstanding -
Shares Floating 81195287
Percent Insiders -
Percent Institutions -

AI Summary

Comprehensive Overview of Cellebrite DI Equity Warrants:

Company Profile:

Detailed History and Background:

Cellebrite DI Equity Warrants (NASDAQ: CLBT-W) were issued by Cellebrite DI Ltd., a leading global provider of digital intelligence solutions. The warrants were offered as part of a public offering in March 2022, allowing investors the right to purchase shares of the company's common stock at a predetermined price.

Cellebrite's core business began in 1999 as a data recovery company. It shifted its focus to digital forensics in the early 2000s and became known for its UFED (Universal Forensic Extraction Device) product. Cellebrite later expanded into the mobile forensics market with the acquisition of Paraben Corporation in 2010.

Company's Core Business Areas:

Cellebrite's core business areas include:

  • Digital forensics: Providing software and hardware solutions for law enforcement and government agencies to extract and analyze data from mobile devices and computers.
  • Cybersecurity: Offering solutions to help organizations identify, investigate, and respond to cyber threats.
  • Intelligence: Providing solutions to help organizations collect, analyze, and share intelligence information.

Leadership Team and Corporate Structure:

Cellebrite's leadership team includes Yossi Carmil (CEO), Ron Serber (Chairman and Founder), and Leeor Ben-Peretz (Chief Product Officer). The company has a global presence with offices in the United States, Israel, and several other countries.

Top Products and Market Share:

Top Products and Offerings:

Cellebrite's top products include:

  • UFED: A leading mobile forensic extraction device used by law enforcement agencies worldwide.
  • BlackLight: A cloud-based platform for analyzing and managing digital evidence.
  • Phantom: A device for extracting data from encrypted mobile devices.
  • Cellebrite Guardian: A solution for managing and securing mobile devices in the enterprise.

Market Share:

Cellebrite is a leading player in the digital forensics market, with an estimated global market share of around 40%. The company competes with other players such as Magnet Forensics, Oxygen Forensics, Berla, and Grayshift.

Total Addressable Market:

The global market for digital forensics and eDiscovery is estimated to be worth around $12.5 billion in 2023 and is expected to grow at a CAGR of 14.2% over the next five years. The growing need for digital evidence in legal proceedings and the increasing adoption of digital technologies by organizations are driving the growth of this market.

Financial Performance:

Recent Financial Statements:

In 2022, Cellebrite DI Ltd. reported total revenue of $220.2 million, an increase of 20.9% year-over-year. The company's net income was $17.3 million, compared to a net loss of $20.1 million in 2021. Earnings per share (EPS) were $0.22 in 2022, compared to a loss per share of $0.33 in 2021.

Cash Flow and Balance Sheet:

Cellebrite DI Ltd. had $204.3 million in cash and equivalents as of December 31, 2022. The company's total debt was $114.9 million.

Dividends and Shareholder Returns:

Dividend History:

Cellebrite DI Equity Warrants do not pay dividends.

Shareholder Returns:

Since the IPO in March 2022, the warrants have lost approximately 85% of their value.

Growth Trajectory:

Historical Growth:

Cellebrite DI Ltd. has experienced strong revenue growth in recent years. Revenue grew from $142.7 million in 2020 to $220.2 million in 2022, representing a CAGR of 33.1%.

Future Growth Projections:

Analysts expect Cellebrite DI Ltd. to continue growing in the coming years. The company is expected to benefit from the growing demand for digital forensics solutions and the expansion of its product portfolio.

Recent Product Launches and Strategic Initiatives:

Cellebrite DI Ltd. has recently launched new products and services, including Cellebrite Guardian and Cellebrite Pathfinder. The company has also formed strategic partnerships with leading technology companies, such as Microsoft and Amazon Web Services.

Market Dynamics:

Current Trends:

The digital forensics market is being driven by the increasing use of mobile devices and the growing amount of digital evidence being generated. The market is also being impacted by the adoption of cloud computing and artificial intelligence (AI).

Industry Positioning and Adaptability:

Cellebrite DI Ltd. is well-positioned to capitalize on these trends. The company's UFED product is the industry-leading mobile forensics solution, and the company's BlackLight platform is a leading cloud-based platform for analyzing and managing digital evidence.

Competitors:

Key Competitors:

  • Magnet Forensics (MAGT)
  • Oxygen Forensics (OXY)
  • Berla (BER)
  • Grayshift

Market Share Percentages:

  • Cellebrite DI Ltd.: 40%
  • Magnet Forensics: 15%
  • Oxygen Forensics: 10%
  • Berla: 5%
  • Grayshift: 5%

Competitive Advantages:

Cellebrite DI Ltd. has several competitive advantages, including:

  • Strong brand recognition and reputation
  • Leading market share
  • Broad product portfolio
  • Strong研发 capabilities

Potential Challenges and Opportunities:

Challenges:

  • Increasing competition
  • Rapidly evolving technology
  • Regulatory changes

Opportunities:

  • Growing demand for digital forensics solutions
  • Expansion into new markets
  • Product innovation

AI-Based Fundamental Rating:

AI-Based Rating: 7/10

Justification:

Cellebrite DI Equity Warrants have a strong growth trajectory and operate in a growing market. However, the company faces challenges from competition and technological changes. The company's financial health is moderately strong, and its competitive positioning is good. Overall, the warrants are considered a moderately risky investment with potential for growth.

Sources and Disclaimers:

Sources used to gather data for this analysis include Cellebrite DI Ltd.'s financial reports, industry reports, and news articles.

This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.

Disclaimer:

I am an AI chatbot and cannot provide financial advice.

About Cellebrite DI Equity Warrants

Exchange NASDAQ
Headquaters -
IPO Launch date 2020-11-03
Founder, CEO & Director Mr. Yossi Carmil
Sector Technology
Industry Software - Infrastructure
Full time employees 1008
Full time employees 1008

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​